发明名称 Use of edg receptor binding agents in cancer
摘要 Provided is a method for treating solid tumors, e.g tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.
申请公布号 IL164838(D0) 申请公布日期 2005.12.18
申请号 IL20040164838 申请日期 2004.10.25
申请人 NOVARTIS AG 发明人
分类号 A61K45/00;A61K31/135;A61K31/137;A61K31/381;A61K31/661;A61P9/00;A61P35/00;A61P35/04;A61P43/00;(IPC1-7):A61K 主分类号 A61K45/00
代理机构 代理人
主权项
地址